Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
ADAG
Stock Latest News
The Fly
Adagene presents data from two Phase 1b/2 studies of muzastotug at AACR
5m ago
ADAG
Premium
Ratings
Adagene: Deepening Dose‑Response Evidence and Strategic Partnership Support Buy Rating on Lead CTLA‑4 Program
11d ago
ADAG
Premium
The Fly
Adagene price target raised to $10 from $9 at Guggenheim
11d ago
ADAG
Premium
The Fly
Adagene 18.666M share Spot Secondary priced at $3.75
15d ago
ADAG
Premium
The Fly
Adagene enters pact with Incyte for combination of muzastotug, INCA33890
15d ago
ADAG
Premium
The Fly
Adagene announces results from the latest data cut of muzastotug study
15d ago
MRK
ADAG
Premium
Company Announcements
Adagene Posts Strong Muzastotug Data and Incyte Collaboration in MSS Colorectal Cancer
15d ago
6K
ADAG
Premium
Company Announcements
Adagene Prices US$70 Million ADS Offering to Bolster Cancer Immunotherapy Pipeline
15d ago
6K
ADAG
Premium
Company Announcements
Adagene Posts 2025 Results as Muzastotug Data, Partnerships Extend Cash Runway to 2028
16d ago
6K
ADAG
Premium
The Fly
Adagene reports FY25 EPS (24c) vs (51c) last year
16d ago
ADAG
Premium
Ratings
Adagene (ADAG): De-Risked CTLA-4 Asset, Emerging Regulatory Clarity, and Strategic Partnerships Underpin Buy Rating
2M ago
ADAG
Premium
Company Announcements
Adagene Outlines 2026 Clinical Milestones and Reports $74.5 Million Year-End Cash Runway
3M ago
6K
ADAG
Premium
The Fly
Adagene provides objective for 2026
3M ago
ADAG
Premium
The Fly
Adagene announces FDA fast track designation for muzastotug
4M ago
MRK
ADAG
Premium
The Fly
Adagene initiated with a Buy at Guggenheim on muzastotug potential
5M ago
ADAG
Premium
The Fly
Adagene initiated with a Buy at Guggenheim
5M ago
ADAG
Premium
The Fly
Adagene initiated with an Outperform at LifeSci Capital
5M ago
ADAG
Premium
Company Announcements
Adagene and Third Arc Bio Forge Licensing Agreement for Cancer Therapy Development
5M ago
6K
ADAG
Premium
The Fly
Adagene announces licensing agreement with Third Arc Bio
5M ago
ADAG
Premium
The Fly
Adagene files to sell 10.625M ordinary shares or 8.5M ADSs for holders
6M ago
ADAG
Premium
The Fly
Adagene says first patient dosed in Phase 2 study of muzastotug, KEYTRUDA
6M ago
MRK
ADAG
Premium
Company Announcements
Tempest Therapeutics and Adagene’s Promising Advances in Liver Cancer Treatment
6M ago
ADAG
TPST
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
